Holland & Knight Health Dose is a weekly publication that provides legislative and regulatory insights to inform stakeholders about developments in Washington, D.C. that affect the health sector. In this edition, we cover several important topics, including the FAA Reauthorization, the House passing the Congressional Budget Office Data Sharing Act, the Senate Committee on Finance releasing a discussion draft on drug shortages, and the House Ways and Means Committee preparing to mark up legislation to extend telehealth waivers.
Additionally, FDA officials will appear before the Energy and Commerce Subcommittee, and there will be House and Senate hearings on administrative and regulatory burdens in healthcare. Last week, there were hearings on cybersecurity threats, Medicaid and long-term services and supports, maternal mortality, and workforce diversity. The Medicare and Social Security Trustees have released their annual reports, and the Departments of Health and Human Services, Labor, and Treasury have released cost-sharing FAQs.
HHS has also released draft guidance for the second cycle of the Medicare Drug Price Negotiation Program, while the FDA has released the Laboratory Developed Test Final Rule. The DACA health coverage rule has also been finalized. Finally, MACPAC appointments are making headlines. For more information on these topics and more from Holland & Knight Health Dose